The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis. Here’s a wrap-up of the headlines from this past month.
The Latest in COVID-19 News and Arthritis
WHO Monitors New ‘Mu’ COVID-19 Variant
The World Health Organization is monitoring a new coronavirus variant called “mu,” which the agency says has mutations that have the potential to evade immunity provided by a previous COVID-19 infection or vaccination.Get details here.
NIH to Study COVID Vaccine Booster in Autoimmune Patients
The National Institute of Allergy and Infectious Diseases has begun a phase 2 trial toassess the antibody response to a booster doseof the Pfizer-BioNTech, Moderna or Janssen vaccine in people with autoimmune disease who did not respond to their original COVID-19 vaccine regimen.
COVID-19 Vaccine Elicits Antibodies in 90% Taking Immunosuppressants
Nearly 90% of people taking immunosuppressants to treat autoimmune conditions produce an antibody response to COVID-19 vaccination, but the response is weaker than those generated by healthy people, according to a new study.Learn more.
Get the latest onArthritis and COVID-19 vaccines FAQsin ourCare and Connectresource hub.
Nasal Cartilage Relieves Knee Osteoarthritis
据巴塞尔大学和巴塞尔大学医院的研究人员称，来自鼻中隔的软骨细胞不仅有助于修复膝关节软骨损伤，它们还可以抵御骨关节炎(OA)中的慢性炎症组织环境，甚至抵消炎症。Read all about it.
Drug Adherence Tied to Genetic Influences, Not Side Effects
The results of new research suggest that drug adherence pertains more to an individual’s genetic predisposition to particular behaviors than to underlying biological factors, such as the adverse effects of a specific drug, the researchers conclude.Learn more.
Cannabis Use Tied to Poorer Outcomes of Total Hip, Knee Replacement
Cannabis use before total knee or hip replacement is associated with increased medical and implant-related complications, according to new research presented at the annual meeting of the American Academy of Orthopaedic Surgeons.阅读更多。
TheArthritis Foundation developed guidance for adults with arthritiswho are exploring CBD use as a treatment for managing pain and other symptoms of arthritis. Learn more aboutwhat you should know about CBDbefore trying it.
And learn more abouttotal kneeandhip arthroplasty．If you’re exploring whether surgery is right for you, listen to the podcast episode onArthritis Pain & Surgery．
In Other Arthritis News
Arthritis@Work for Corporate Wellness Programs
The Arthritis Foundation is offering employers free turnkey tools and resources to support their employees with arthritis. As the second largest driver of employee health care costs, arthritis is responsible for 172 million lost workdays each year. Integrated into existing corporate wellness programs,Arthritis@Work是一个双赢的方式，为雇主保护他们的底线，照顾那些关心他们的业务。
Novartis Gets FDA Fast-Track Designation for LNA043 in Knee OA
The Swiss drug maker said it isdeveloping LNA043 as a potential first-in-class disease-modifying treatment for OA．FDA的快速通道项目旨在促进严重或潜在威胁生命的疾病的治疗方法的发展和加快审查，而这些疾病的医疗需求没有得到满足。
No Sex Difference Seen for Ankylosing Spondylitis
The incidence of ankylosing spondylitis (AS) did not differ between men and women in a large study of military personnel, which called into question the previous assumption of male predominance for this disease.Read about the study.
Osteoarthritis: New Genetic Risk Factors and Novel Drug Targets
Researchers have found new genetic risk factors for OA and identified novel drug targets. Their finding is a milestone toward the development of the first ever curative treatment for OA.Learn more.
TPX-100 Delays Bone Shape Change, Stabilizes Cartilage in Bilateral Knee OA
TPX-100, a promotor of osteoblast and chondroblast differentiation, is a potential therapy for OA. A new retrospective study compared MRI 3D femoral bone shape changes (B-scores) after intra-articular TPX-100 or placebo and analyzed therelationship between cartilage thickness and bone shape changeover 12 months.
For pain management resources and tools, visitarthritis.org/pain．